Home / Ustekinumab / Belgium
BE ATC L04AC05 · updated 2 Nov 2026
Ustekinumab shortage in Belgium
Is there a Ustekinumab shortage in Belgium?
Yes. As of 2 Nov 2026, 4 Ustekinumab products are reported short in Belgium, the first since 21 Apr 2026. The company estimate for the return is 30 Nov 2026 (latest 21 Apr 2027). Main reason: other.
Also short in Italy, Spain, Ireland. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Usymro 45 mg inj. sol. s.c. pre-filled syr. 0.5 ml | Gedeon Richter | 21 Apr 2026 | 21 Apr 2027 | Other Other reason |
| BE | Usymro 90 mg inj. sol. s.c. pre-filled syr. 1 ml | Gedeon Richter | 21 Apr 2026 | 21 Apr 2027 | Other Other reason |
| BE | Imuldosa 130 mg inf. sol. (conc.) i.v. vial 26 ml | Accord Healthcare | 28 May 2026 | 30 Nov 2026 | Other Other reason |
| BE | Yesintek 90 mg inj. sol. s.c. pre-filled pen 1 ml | Biosimilar Collaborations Ireland | 1 Oct 2026 | not given | Manufacturing problem Delay in production |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.